Findings seen over three months in men with low-grade prostate cancer, hypogonadism treated with radical prostatectomy.

PROCEPT BioRobotics (Nasdaq: PRCT) today announced two milestones in its WATER IV prostate cancer clinical program: ...

Researchers at VCU Massey Cancer Center have uncovered a novel function of the gene PLK1 (polo-like kinase 1) that helps prostate cancer cells metastasize (spread) to other parts of the body. This ...

CHICAGO -- Patients with advanced prostate cancer treated with enzalutamide (Xtandi) had a significantly greater decline in ...

The NeuroSAFE technique significantly improves erectile function outcomes post-prostatectomy, nearly doubling the number of patients with no or mild erectile dysfunction. Intraoperative tissue ...

Abhinav Sidana, MD, a urologic oncologist at the University of Chicago Medicine (UChicago Medicine), has performed the first ...

In a randomized clinical trial, Mass General Brigham researchers found testosterone replacement therapy also improved quality of life for men who had undergone radical prostatectomy ...

Researchers at Columbia University Irving Medical Center have identified a gene that drives the development of neuroendocrine ...

Over half of patients in a randomized trial switch from enzalutamide to darolutamide because of cognitive issues; no one switches in the opposite direction.

Majority of men in UK will not be offered routine prostate cancer screening - Black men have double the risk of prostate ...